Immune Oncology Research Institute shared on LinkedIn:
“The BPDCN international registry continues to record successes.
Dr. Astghik Voskanyan, a clinical research physician at IMMONC, introduced developments in the BPDCN international registry during an interview with VJHemOnc at the 29th EHA Congress in Madrid.
BPDCN International Registry.”
Read further.
Source: Immune Oncology Research Institute/LinkedIn